Literature DB >> 5092786

Studies on new antibiotic lividomycins. IV. Structure of lividomycin A.

T Oda, T Mori, Y Kyŏtani, M Nakayama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5092786     DOI： 10.7164/antibiotics.24.511

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Selective phosphorylation of the 5''-hydroxy group of ribostamycin by a new enzyme from Pseudomonas aeruginosa.

Authors:  M Kida; S Igarasi; T Okutani; T Asako; K Hiraga
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

3.  Mode of action of lividomycin on protein synthesis in Escherichia coli.

Authors:  M Yamaguchi; J Eda; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

4.  Activity of lividomycin against Pseudomonas aeruginosa: its inactivation by phosphorylation induced by resistant strains.

Authors:  F Kobayashi; M Yamaguchi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

5.  Antibacterial activity of lividomycin toward R factor-resistant strains of Escherichia coli.

Authors:  M Yamaguchi; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

6.  Phosphorylation of lividomycin by Escherichia coli carrying an R factor.

Authors:  M Yamaguchi; T Koshi; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.